Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy

This publication has 21 references indexed in Scilit:

• Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
  Kidney International, 2000
• Renoprotective therapy: titration against urinary protein excretion
  The Lancet, 1999
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
  The Lancet, 1997
• Effect of Angiotensin Converting Enzyme Inhibition by Perindopril on Proteinuria of Primary Renal Diseases
  American Journal of Nephrology, 1997
• Antiproteinuric Effect Predicts Renal Protection by Angiotensin-Converting Enzyme Inhibition in Rats with Established Adriamycin Nephrosis
  Clinical Science, 1996
• Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy
  The Lancet, 1996
• Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment
  Diabetologia, 1994
• The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
  New England Journal of Medicine, 1994
• Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?
  Kidney International, 1994
• The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
  New England Journal of Medicine, 1993